Thomas Joe 4
4 · Outlook Therapeutics, Inc. · Filed Oct 7, 2019
Insider Transaction Report
Form 4
Thomas Joe
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-10-03+15,000→ 15,000 totalExercise: $1.40Exp: 2029-10-03→ Common Stock (15,000 underlying) - Award
Stock Option (Right to Buy)
2019-10-03$0.99/sh+48,207$47,498→ 48,207 totalExercise: $1.40Exp: 2029-10-03→ Common Stock (48,207 underlying)
Footnotes (2)
- [F1]The options were granted under the Issuer's 2015 Equity Incentive Plan (the "2015 Plan") and shall vest in full on the one year anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan.
- [F2]The options were granted under the 2015 Plan in lieu of $47,500 cash fees payable under the Issuer's non-employee Director compensation program and vest in four equal quarterly installments on the last day of each fiscal quarter such that they are vested in full on September 30, 2020, subject to the Reporting Person providing continuous service to the Issuer on such date and subject to acceleration upon a Change in Control as defined in the 2015 Plan.